Companies in the genetics sector developing innovative solutions and technologies.
Explore 307 recently funded genetics companies with verified founder contact information and fundraising data.
Protillion Biosciences specializes in the design and development of protein-based drugs.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Concinnity Genetics transform the safety of gene therapies by designing novel control mechanisms using AI platform.
ActX is a dynamic venture that focuses on making patient genomic information truly useful in everyday medical practice.
Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Zymtronix develops a patented platform technology that allows innovative and efficient enzyme processes.
Limula offers a modular and automated solution for on-demand and at-scale manufacturing of cell therapies.
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Tektite Genome is an AI-driven genomics Biotech company that develops and represents non-toxic products and services.
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
Inflection Point Genetics specializes in developing genetic engineering research technology.
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.
The World's First Genetically Personalised Nutrition Shake
Dovetail uses proximity ligation technology in genomics, providing insights into genomic structures and variations.
MicroByre is a biotechnology company that specializes in microbiology, synthetic biology, molecular biology, and machine learning..
MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.
The Embryo Corporation is a biotech company that develops new organisms and biological traits using AI-driven genetic engineering.
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 307 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked